NewEdge Advisors’s Innoviva INVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$765K Buy
33,695
+1,048
+3% +$24K ﹤0.01% 1843
2026
Q1
$761K Sell
32,647
-3,337
-9% -$71.9K ﹤0.01% 1672
2025
Q4
$719K Buy
35,984
+15,899
+79% +$310K ﹤0.01% 1696
2025
Q3
$367K Buy
20,085
+1,407
+8% +$27.4K ﹤0.01% 2032
2025
Q2
$375K Buy
18,678
+5,284
+39% +$102K ﹤0.01% 1876
2025
Q1
$243K Buy
+13,394
New +$240K ﹤0.01% 2011
2024
Q2
Sell
-779
Closed -$11.9K 3898
2024
Q1
$11.9K Sell
779
-879
-53% -$13.8K ﹤0.01% 2817
2023
Q4
$26.6K Buy
+1,658
New +$23.2K ﹤0.01% 2466
2023
Q1
Sell
-284
Closed -$3.51K 3783
2022
Q4
$3.51K Buy
+284
New +$3.73K ﹤0.01% 2703
2017
Q3
Sell
-1,300
Closed -$16.5K 721
2017
Q2
$16.5K Buy
+1,300
New +$16.3K ﹤0.01% 797

Other funds holding INVA

NewEdge Advisors's INVA Position: Q2 2026 in Review

NewEdge Advisors increased its Innoviva (INVA) stake by 3.2% in Q2 2026, buying an estimated $24K and bringing the position to 33,695 shares worth $765K. The position accounts for ﹤0.01% of the portfolio, ranked #1843.

NewEdge Advisors first reported a position in INVA in Q2 2017 and has held it in 10 quarters since. 308 funds tracked by Wall St. Rank hold INVA as of Q2 2026.

  • NewEdge Advisors held 33,695 shares of Innoviva worth $765K as of Q2 2026.
  • NewEdge Advisors bought 1,048 Innoviva shares in Q2 2026, an estimated $24K.
  • Innoviva made up ﹤0.01% of NewEdge Advisors's portfolio in Q2 2026, its #1843 holding.
  • NewEdge Advisors first reported a position in Innoviva in Q2 2017 and has held it in 10 quarters since.
  • 308 funds tracked by Wall St. Rank held Innoviva as of Q2 2026.

Based on NewEdge Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.